Literature DB >> 10219400

MR imaging of Dejerine-Sottas disease.

D D Maki1, D M Yousem, C Corcoran, S L Galetta.   

Abstract

We report the MR findings in two patients with clinically and histologically proved Dejerine-Sottas disease. One patient had spinal involvement with multiple thickened and clumped nerve roots of the cauda equina; the second had multiple enlarged and enhancing cranial nerves. Although these findings are not specific for Dejerine-Sottas disease, they are suggestive of the diagnosis, which is further corroborated with history and confirmed with sural nerve biopsy and laboratory studies.

Entities:  

Mesh:

Year:  1999        PMID: 10219400

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

1.  Lipofibromatous Hamartoma of the Median Nerve: A Case Report.

Authors:  Haris N Shekhani; Tarek Hanna; Jamlik-Omari Johnson
Journal:  J Radiol Case Rep       Date:  2016-11-30

2.  [Hereditary motor and sensory neuropathy (HMSN) with hypertrophy of the cauda equina and concomitant demyelinating white matter lesions].

Authors:  B B Ertl-Wagner; C Helmchen; A Stäbler; F Fassmann; M F Reiser
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

3.  Intracranial and spinal MR imaging findings associated with Krabbe's disease: case report.

Authors:  C A Given; C C Santos; D D Durden
Journal:  AJNR Am J Neuroradiol       Date:  2001-10       Impact factor: 3.825

4.  Spinal cord and cauda equina MRI findings in metachromatic leukodystrophy: case report.

Authors:  Irene Toldo; Carla Carollo; Pier Antonio Battistella; Anna Maria Laverda
Journal:  Neuroradiology       Date:  2005-07-15       Impact factor: 2.804

5.  A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.

Authors:  Nozomu Matsuda; Koushi Ootsuki; Shunsuke Kobayashi; Ayaka Nemoto; Hitoshi Kubo; Shin-Ichi Usami; Kazuaki Kanani
Journal:  BMC Neurol       Date:  2021-06-25       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.